Heron Therapeutics, Inc. (HRTX) has a market capitalization of $151.1M and trades at $0.96. The 52-week range is 0.74-2.61.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -8, Earnings Per Share (EPS) of $-0.12, annual revenue of $154.9M.
The stock has a beta of 1.42, operates in the Healthcare sector.
